Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 12:23 pm Purchase |
2025-04-16 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Radoff Bradley Louis | 3,380,100 4.000% |
275,000 (+8.86%) |
Filing History |
| 2025-03-21 11:58 am Purchase |
2025-03-20 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Radoff Bradley Louis | 3,105,100 3.600% |
285,100 (+10.11%) |
Filing History |
| 2025-03-04 09:27 am Purchase |
2025-02-27 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Radoff Bradley Louis | 2,820,000 3.300% |
2,820,000 (New Position) |
Filing History |
| 2025-02-14 12:47 pm Sale |
2024-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 3,341,653 4.000% |
-2,100,243 (-38.59%) |
Filing History |
| 2024-12-16 09:50 am Purchase |
2024-12-13 | 13D | Atea Pharmaceuticals, Inc. AVIR |
BML Investment Partners, L.P. | 7,216,312 8.500% |
1,614,233 (+28.81%) |
Filing History |
| 2024-11-15 10:34 am Sale |
2024-09-30 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 5,441,896 6.400% |
-1,553,965 (-22.21%) |
Filing History |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Atea Pharmaceuticals, Inc. AVIR |
FMR CORP | 6,618,297 7.839% |
1,267,638 (+23.69%) |
Filing History |
| 2024-02-15 11:35 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing History |
| 2024-02-15 09:15 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing History |
| 2024-02-14 8:02 pm Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital LLC | 6,995,861 8.400% |
811,000 (+13.11%) |
Filing History |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | Atea Pharmaceuticals, Inc. AVIR |
The Vanguard Group | 4,599,710 5.510% |
-1,489,812 (-24.47%) |
Filing History |
| 2024-02-13 4:30 pm Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Sommadossi Jean-Pierre | 8,162,914 9.600% |
688,032 (+9.20%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Atea Pharmaceuticals, Inc. AVIR |
FMR CORP | 5,350,659 6.412% |
-1,723,628 (-24.36%) |
Filing History |
| 2024-02-07 09:25 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BML Investment Partners, L.P. | 5,602,079 6.700% |
0 (Unchanged) |
Filing History |
| 2024-02-07 09:14 am Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BML Investment Partners, L.P. | 5,602,079 6.700% |
1,418,434 (+33.90%) |
Filing History |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BLACKROCK INC BLK |
9,443,887 11.300% |
605,872 (+6.86%) |
Filing History |
| 2023-11-28 06:00 am Purchase |
2023-11-22 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 4,033,463 4.800% |
1,007,008 (+33.27%) |
Filing History |
| 2023-11-07 3:33 pm Purchase |
2023-10-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BLACKROCK INC BLK |
8,838,015 10.600% |
804,443 (+10.01%) |
Filing History |
| 2023-10-02 11:45 am Purchase |
2023-09-25 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BML Investment Partners, L.P. | 4,183,645 5.000% |
4,183,645 (New Position) |
Filing History |
| 2023-09-11 08:23 am Sale |
2023-09-08 | 13G | Atea Pharmaceuticals, Inc. AVIR |
FMR CORP | 7,074,287 8.482% |
-4,663,122 (-39.73%) |
Filing History |